Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Chemoradiotherapy in Cervical Cancer
NCT01158248Phase 2Unknown
- Sponsor
- Medical University of Innsbruck
- Start
- Feb 2010
- Primary completion
- Mar 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in Cervical Cancer (CC), sponsored by Medical University of Innsbruck. Status: unknown.
02
Drugs
panitumumab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01158248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158248.